A clinical, pathologic, and molecular study of P53 and murine double minute 2 in penile carcinogenesis and its relation to prognosis

Rafael Malagoli Rocha, Julianna Alves Ignácio, José Jordán, Dirce Maria Carraro, Bianca Lisboa, Ademar Lopes, Kátia Cândido Carvalho, Isabela Werneck Da Cunha, Antônio Cubilla, Gustavo Cardoso Guimarães, José Vassallo, Fernando Augusto Soares

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Penile carcinoma constitutes up to 16% of male malignancies in developing countries. Changes in the P53 and murine double minute 2 pathway are important events in various cancers. Associate alterations in murine double minute 2 and P53 expression were evaluated by molecular techniques, with the clinical data of 297 cases of penile carcinoma. Automated immunohistochemistry was performed for murine double minute 2 and P53 using the primary antibodies SPM14 and DO7, respectively. Fluorescent in situ hybridization was performed using the probes murine double minute 2 at 12q15 and TP53 at 17p13.1. Slides were digitalized, and bright-field and fluorescent images were analyzed. TP53 was sequenced in 16 cases. The expression of P53 was higher in poorly differentiated, infiltrative border, corpus spongiosum, corpora cavernosa, and invasive urethral carcinomas. Patients who died of disease also expressed higher levels of P53. P53-negative tumors were associated with higher overall survival. Murine double minute 2 showed no difference of expression in any group of tumors, no correlation with P53 expression. No alterations in genes or chromosomes were observed. Mutations in TP53 were observed in 4 of 16 cases: p.T170M, p.L252P, p.C176Y, and the novel c.803-810del8; these changes correlated with P53 expression by immunohistochemistry. Murine double minute 2 is not useful in the prognosis of penile carcinoma by immunohistochemistry. Additional studies on the transcriptional, posttranscriptional, and epigenetic aspects are necessary to understand the interactions between P53 and murine double minute 2 because we did not observe any numeric alterations by fluorescent in situ hybridization. Examining P53 is helpful in identifying patients with more aggressive tumors and may be crucial in selecting the most suitable surgical procedure.

Original languageEnglish (US)
Pages (from-to)481-488
Number of pages8
JournalHuman Pathology
Volume43
Issue number4
DOIs
StatePublished - Apr 1 2012

Fingerprint

Carcinogenesis
Carcinoma
Immunohistochemistry
Neoplasms
Fluorescence In Situ Hybridization
Epigenomics
Developing Countries
Chromosomes
Mutation
Survival
Antibodies
Genes

Keywords

  • Molecular pathogenesis
  • Murine double minute 2
  • P53
  • Penile cancer
  • Prognosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

A clinical, pathologic, and molecular study of P53 and murine double minute 2 in penile carcinogenesis and its relation to prognosis. / Rocha, Rafael Malagoli; Ignácio, Julianna Alves; Jordán, José; Carraro, Dirce Maria; Lisboa, Bianca; Lopes, Ademar; Carvalho, Kátia Cândido; Da Cunha, Isabela Werneck; Cubilla, Antônio; Guimarães, Gustavo Cardoso; Vassallo, José; Soares, Fernando Augusto.

In: Human Pathology, Vol. 43, No. 4, 01.04.2012, p. 481-488.

Research output: Contribution to journalArticle

@article{1b217995c3414596aa83483700599527,
title = "A clinical, pathologic, and molecular study of P53 and murine double minute 2 in penile carcinogenesis and its relation to prognosis",
abstract = "Penile carcinoma constitutes up to 16{\%} of male malignancies in developing countries. Changes in the P53 and murine double minute 2 pathway are important events in various cancers. Associate alterations in murine double minute 2 and P53 expression were evaluated by molecular techniques, with the clinical data of 297 cases of penile carcinoma. Automated immunohistochemistry was performed for murine double minute 2 and P53 using the primary antibodies SPM14 and DO7, respectively. Fluorescent in situ hybridization was performed using the probes murine double minute 2 at 12q15 and TP53 at 17p13.1. Slides were digitalized, and bright-field and fluorescent images were analyzed. TP53 was sequenced in 16 cases. The expression of P53 was higher in poorly differentiated, infiltrative border, corpus spongiosum, corpora cavernosa, and invasive urethral carcinomas. Patients who died of disease also expressed higher levels of P53. P53-negative tumors were associated with higher overall survival. Murine double minute 2 showed no difference of expression in any group of tumors, no correlation with P53 expression. No alterations in genes or chromosomes were observed. Mutations in TP53 were observed in 4 of 16 cases: p.T170M, p.L252P, p.C176Y, and the novel c.803-810del8; these changes correlated with P53 expression by immunohistochemistry. Murine double minute 2 is not useful in the prognosis of penile carcinoma by immunohistochemistry. Additional studies on the transcriptional, posttranscriptional, and epigenetic aspects are necessary to understand the interactions between P53 and murine double minute 2 because we did not observe any numeric alterations by fluorescent in situ hybridization. Examining P53 is helpful in identifying patients with more aggressive tumors and may be crucial in selecting the most suitable surgical procedure.",
keywords = "Molecular pathogenesis, Murine double minute 2, P53, Penile cancer, Prognosis",
author = "Rocha, {Rafael Malagoli} and Ign{\'a}cio, {Julianna Alves} and Jos{\'e} Jord{\'a}n and Carraro, {Dirce Maria} and Bianca Lisboa and Ademar Lopes and Carvalho, {K{\'a}tia C{\^a}ndido} and {Da Cunha}, {Isabela Werneck} and Ant{\^o}nio Cubilla and Guimar{\~a}es, {Gustavo Cardoso} and Jos{\'e} Vassallo and Soares, {Fernando Augusto}",
year = "2012",
month = "4",
day = "1",
doi = "10.1016/j.humpath.2011.06.013",
language = "English (US)",
volume = "43",
pages = "481--488",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - A clinical, pathologic, and molecular study of P53 and murine double minute 2 in penile carcinogenesis and its relation to prognosis

AU - Rocha, Rafael Malagoli

AU - Ignácio, Julianna Alves

AU - Jordán, José

AU - Carraro, Dirce Maria

AU - Lisboa, Bianca

AU - Lopes, Ademar

AU - Carvalho, Kátia Cândido

AU - Da Cunha, Isabela Werneck

AU - Cubilla, Antônio

AU - Guimarães, Gustavo Cardoso

AU - Vassallo, José

AU - Soares, Fernando Augusto

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Penile carcinoma constitutes up to 16% of male malignancies in developing countries. Changes in the P53 and murine double minute 2 pathway are important events in various cancers. Associate alterations in murine double minute 2 and P53 expression were evaluated by molecular techniques, with the clinical data of 297 cases of penile carcinoma. Automated immunohistochemistry was performed for murine double minute 2 and P53 using the primary antibodies SPM14 and DO7, respectively. Fluorescent in situ hybridization was performed using the probes murine double minute 2 at 12q15 and TP53 at 17p13.1. Slides were digitalized, and bright-field and fluorescent images were analyzed. TP53 was sequenced in 16 cases. The expression of P53 was higher in poorly differentiated, infiltrative border, corpus spongiosum, corpora cavernosa, and invasive urethral carcinomas. Patients who died of disease also expressed higher levels of P53. P53-negative tumors were associated with higher overall survival. Murine double minute 2 showed no difference of expression in any group of tumors, no correlation with P53 expression. No alterations in genes or chromosomes were observed. Mutations in TP53 were observed in 4 of 16 cases: p.T170M, p.L252P, p.C176Y, and the novel c.803-810del8; these changes correlated with P53 expression by immunohistochemistry. Murine double minute 2 is not useful in the prognosis of penile carcinoma by immunohistochemistry. Additional studies on the transcriptional, posttranscriptional, and epigenetic aspects are necessary to understand the interactions between P53 and murine double minute 2 because we did not observe any numeric alterations by fluorescent in situ hybridization. Examining P53 is helpful in identifying patients with more aggressive tumors and may be crucial in selecting the most suitable surgical procedure.

AB - Penile carcinoma constitutes up to 16% of male malignancies in developing countries. Changes in the P53 and murine double minute 2 pathway are important events in various cancers. Associate alterations in murine double minute 2 and P53 expression were evaluated by molecular techniques, with the clinical data of 297 cases of penile carcinoma. Automated immunohistochemistry was performed for murine double minute 2 and P53 using the primary antibodies SPM14 and DO7, respectively. Fluorescent in situ hybridization was performed using the probes murine double minute 2 at 12q15 and TP53 at 17p13.1. Slides were digitalized, and bright-field and fluorescent images were analyzed. TP53 was sequenced in 16 cases. The expression of P53 was higher in poorly differentiated, infiltrative border, corpus spongiosum, corpora cavernosa, and invasive urethral carcinomas. Patients who died of disease also expressed higher levels of P53. P53-negative tumors were associated with higher overall survival. Murine double minute 2 showed no difference of expression in any group of tumors, no correlation with P53 expression. No alterations in genes or chromosomes were observed. Mutations in TP53 were observed in 4 of 16 cases: p.T170M, p.L252P, p.C176Y, and the novel c.803-810del8; these changes correlated with P53 expression by immunohistochemistry. Murine double minute 2 is not useful in the prognosis of penile carcinoma by immunohistochemistry. Additional studies on the transcriptional, posttranscriptional, and epigenetic aspects are necessary to understand the interactions between P53 and murine double minute 2 because we did not observe any numeric alterations by fluorescent in situ hybridization. Examining P53 is helpful in identifying patients with more aggressive tumors and may be crucial in selecting the most suitable surgical procedure.

KW - Molecular pathogenesis

KW - Murine double minute 2

KW - P53

KW - Penile cancer

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=84858154642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858154642&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2011.06.013

DO - 10.1016/j.humpath.2011.06.013

M3 - Article

C2 - 21925707

AN - SCOPUS:84858154642

VL - 43

SP - 481

EP - 488

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 4

ER -